Rat PK for the DYT1 lead compound
Cancelled Solicitation Posted
- Solicitation number
- 75N98026Q00987
- Agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- Q301 Reference Laboratory Testing
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institutes of Health, Office of Acquisitions, seeks a rat pharmacokinetic study for a DYT1 lead compound, a small molecule modulator to treat dystonia type-1, with proposals due August 24, 2026. This is an unrestricted, full and open competitive acquisition under FAR 12.603 for commercial items, conducted as a combined synopsis/solicitation.
Delivery location is NIH/NCATS, 9808 Medical Center Drive, Rockville, Maryland. The period of performance runs September 4 through October 3, 2026, with delivery expected 2–3 weeks after order placement. The estimated cost is $9,850 for one study. The NAICS code is 541715, Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology); the small business size standard is 1,000 employees. The PSC code is Q301, Reference Laboratory Testing.
Responses must include unit and total price, shipping and handling costs, delivery timeframe, F.O.B. point, product/service description, Unique Entity Identifier, Taxpayer Identification Number, and business size certification. All offerors must be actively registered in the System for Award Management. Evaluation factors are price, technical capability, past performance, and delivery schedule. The Government will award a firm-fixed-price contract representing the best value. Data will be shared via email to Samarjit Patnaik and Vinoth Kumar Chenniappan. Submit responses electronically to Jaddua Johnston, Contracting Specialist, at Jaddua.Johnston@nih.gov or call 240-569-0006.
Notice text
(i) This is a combined synopsis/solicitation for commercial items prepared in accordance with FAR Subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes only solicitation; proposals are being requested, and a separate written solicitation will not be issued.
(ii) The solicitation number is 75N98026Q00987. This solicitation is issued as a competitive combined synopsis/solicitation for commercial products or commercial services. The Government intends to award a contract or purchase order resulting from this solicitation using full and open competition.
This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold (if applicable).
The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, seeks to award a (Firm-Fixed-Price) to the offeror responsible whose proposal represents the best value to the Government.
(iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular effective August 7, 2026
(iv) The associated NAICS code is 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) and the small business size standard is 1000 employees.
This requirement is unrestricted.
Files
| File | Type | Posted |
|---|---|---|
| Sol_75N98026Q00987.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity